Skip to content

Cubital tunnel release

Surgeon-side topic for cubital tunnel release. Backed by 354 articles from the corpus, retrieved via combined MeSH + title-text matching.

Overview

Cubital tunnel release addresses ulnar neuropathy, with outcomes often reflecting symptom relief both within and outside the ulnar nerve distribution [1]. The procedure is indicated for patients presenting with hand symptoms that respond to release [3], including those with bony encasement from heterotopic ossification, where treatment yields superior range of motion and resolved neuropathy [9]. Notably, patients undergoing carpal tunnel release are 15 times more likely to require subsequent cubital tunnel release, while those having cubital tunnel release are 11.5 times more likely to undergo carpal tunnel release [6].

Current management strategies encompass contemporary research on anatomy and clinical presentation [4], with a focus on comparing open versus endoscopic techniques to determine the optimal efficacy and safety profile [5]. Endoscopic decompression has gained popularity for its minimally invasive nature, offering smaller incisions, faster recovery, and minimal scarring with outcomes comparable to more invasive procedures [13, 27]. Revision cases, particularly those involving submuscular transposition, generally provide relief of symptoms [2].

Short-term complication rates vary by technique: in situ release is 3.6%, transposition is 9.6%, and the overall rate for cubital tunnel surgery is 5.6% [21]. Concomitant endoscopic release of both carpal and cubital tunnels demonstrates complications comparable to single-site procedures [11]. While endoscopic release may lead to ulnar nerve subluxation requiring specific treatment guidelines [8], early results remain encouraging with minimal complications [13].

Anatomy & Pathophysiology

Cubital tunnel syndrome represents the second most common entrapment neuropathy of the upper extremity, occurring after carpal tunnel syndrome [10], with an incidence of nearly 21 cases per 100,000 people per year [10] and a prevalence in the United States population between 1.8% and 5.9% [32]. While pain is not a common symptom, an aching pain localized to the elbow or proximal forearm may be reported [10]. Typical presentation includes worsening sensory numbness of the hand and digits in an ulnar distribution, progressing to motor weakness of the hypothenar musculature and clawing of the hand [10].

The ulnar nerve's posterior location and superficial course make it particularly susceptible to irritation, compression, and traction during elbow motion [31]. Elbow flexion diminishes the volume of the cubital tunnel and elongates the ulnar nerve, suggesting that both compression and nerve tension contribute to cubital tunnel syndrome [31]. The area within the cubital tunnel decreases beyond 90° of elbow flexion [41], and the humeral trochlea protrudes into the cubital tunnel during flexion, causing dynamic morphologic changes in the ulnar nerve [44]. With elbow flexion, the ulnar nerve does not move appreciably in the distal-proximal direction directly at the cubital tunnel, but maximal excursion occurs in the fatty region proximal to the elbow [43]. Shoulder position changes the ulnar nerve strain around the elbow in living patients with cubital tunnel syndrome [52], and increased elbow flexion influences the intraneural blood flow of the ulnar nerve [55]. The mechanism of symptom provocation by the elbow flexion test cannot be explained simply by dynamic pressure in the cubital tunnel, as other pathophysiological factors may contribute [57]. Ulnar nerve gliding is most severe during passive wrist movement in elbow flexion and forearm supination [58].

Compression of the ulnar nerve may occur at the ligament of Struthers (medial intermuscular septum), fascial bands distally between the ulnar and humeral heads of the flexor carpi ulnaris, or about the roof of the cubital tunnel in patients with an anconeus epitrochlearis [31]. Bony encasement of the ulnar nerve can occur secondary to heterotopic ossification of the elbow [9]. Subluxation or dislocation of the ulnar nerve during elbow flexion can be palpated and may be associated with increased symptoms [10], and ulnar nerve mobility may be associated with dislocation of the medial head of the triceps [10].

The dorsal ulnar cutaneous nerve arises from the ulnar nerve approximately 6 cm proximal to the wrist and innervates the ulnar aspect of the dorsum of the hand [10]. Diminished sensation in the dorsal ulnar cutaneous nerve territory indicates a lesion proximal to this branch, likely within the cubital tunnel [10], whereas preserved dorsal sensation suggests the lesion may be localized to Guyon canal in the wrist rather than the cubital tunnel [10]. Ultrasonography can demonstrate hypoechoic, enlarged nerve fascicles with sensitivity ranging from 46% to 100% and specificity from 43% to 97% [10]. MRI can demonstrate enlarged, T2-hyperintense nerve lesions proximal to a point of compression with distal muscle atrophy, with sensitivity as high as 95% and specificity of 80% [10]. The ulnar tunnel is a dynamic space with dimensions and relationships influenced by wrist motion [40]. Chronic structural adaptations of the shoulder and elbow are not significantly correlated in professional baseball pitchers regarding strength or range of motion [39], yet more than half of athletes undergoing ulnar nerve transposition and decompression surgery sustained an ipsilateral shoulder or elbow injury [53].

Classification

Outcome Classification: Improvement in pain and function following cubital tunnel release may extend to symptoms both within and outside the ulnar nerve distribution [1]. Clinically relevant relief of hand symptoms is achieved with cubital tunnel release [3]. The majority of patients undergoing revision cubital tunnel release with submuscular transposition experience symptom relief [2].

Revision Risk: The risk of revision cubital tunnel release is low [14]. The incidence of failure requiring ipsilateral revision surgery after cubital tunnel release remained steadily low at 1.4% during the study period [22].

Classification Systems: The study is the first to classify ulnar nerve subluxation after endoscopic cubital tunnel release and describe a guideline for ensuing treatment [8]. The panel reached consensus on the designation of critical or noncritical for all steps of an ulnar nerve transposition, with the exception of one step [20].

Other Considerations: Patients who undergo carpal tunnel release are 15 times more likely to undergo cubital tunnel release than the general population, while patients who undergo cubital tunnel release are 11.5 times more likely to undergo carpal tunnel release [6]. Lower reimbursement is likely related to the lack of a dedicated current procedural terminology code for endoscopic cubital tunnel release [29]. Current literature reviews anatomy, clinical presentation, and management options with an emphasis on contemporary outcomes [4], compares open and endoscopic release regarding efficacy, patient experience, and safety [5], summarizes the most up-to-date literature to propose a treatment algorithm [26], and represents the best cumulative evidence to date examining surgical management [7].

Clinical Presentation

Cubital tunnel syndrome is the second most common entrapment neuropathy of the upper extremity, occurring after carpal tunnel syndrome [10], with an incidence of nearly 21 cases per 100,000 people per year [10] and a prevalence in the United States population between 1.8% and 5.9% [32]. Pain is not a common symptom, though an aching pain localized to the elbow or proximal forearm may be reported [10]. Patients typically present with worsening sensory numbness of the hand and digits in an ulnar distribution [10], with dysesthesias in the small finger and ulnar side of the ring finger exacerbated by prolonged elbow flexion [31]. Symptoms may progress to involve motor weakness of the hypothenar musculature and clawing of the hand due to loss of intrinsic musculature [10], with later complaints of grip weakness and hand atrophy [31]. More advanced findings include intrinsic muscle weakness, hypothenar wasting, and resulting functional impairment [31], with men more likely to present with muscle atrophy than women [34].

The most common site of ulnar nerve entrapment is about the elbow [31], where elbow flexion diminishes the volume of the cubital tunnel and elongates the nerve, suggesting that both compression and nerve tension contribute to cubital tunnel syndrome [31]. Ulnar nerve compression may stem from space-occupying lesions, compression proximally at the ligament of Struthers (medial intermuscular septum), and fascial bands distally between the ulnar and humeral heads of the flexor carpi ulnaris [31]. Compression may also occur about the roof of the cubital tunnel in patients with an anconeus epitrochlearis [31]. Patients who undergo carpal tunnel release are 15 times more likely to undergo cubital tunnel release than the general population [6], while patients who undergo cubital tunnel release are 11.5 times more likely to undergo carpal tunnel release [6].

Diagnosis is made by clinical history and physical examination, with adjunct electrophysiology and imaging as needed [10]. A detailed ulnar nerve examination should include attention to the presence or absence of sensation in the distribution of the dorsal ulnar cutaneous nerve [10], which innervates the ulnar aspect of the dorsum of the hand and arises from the ulnar nerve approximately 6 cm proximal to the wrist [10]. If sensation is diminished in the dorsal ulnar cutaneous nerve territory, the localization is proximal to this branch and likely within the cubital tunnel [10]; with preserved dorsal sensation, the lesion may be localized to Guyon canal in the wrist [10]. Electrophysiology is helpful to ensure proper diagnosis and targeted treatment [10]. Subluxation or dislocation of the ulnar nerve during elbow flexion can be palpated and may be associated with increased symptoms [10], and ulnar nerve mobility may be associated with dislocation of the medial head of the triceps [10].

Ultrasonography can demonstrate hypoechoic, enlarged nerve fascicles with a sensitivity of 46% to 100% and specificity of 43% to 97% [10], while MRI can demonstrate enlarged, T2-hyperintense nerve lesions proximal to a point of compression with distal muscle atrophy, with sensitivity as high as 95% and specificity of 80% [10]. MRI and ultrasonography are utilized to aid in the diagnosis of ulnar neuropathy at the elbow [10]. Conservative management via activity modification, anti-inflammatory medications, and therapy can be attempted after diagnosis [10], though many cases of cubital tunnel syndrome require surgical intervention [10].

In mild to moderate cases, there is a return of "painless" functional sensation to the digits innervated by the ulnar nerve after surgery [23], and surgery results in reinnervation of the muscles innervated by the ulnar nerve distal to the cubital tunnel [23]. Patients with severe and chronic compression, atrophy, and dense sensory loss should be cautioned that surgery will arrest progression and improve symptoms but will not return normal strength or sensation [23]. In a follow-up study of 119 operated cases at least 2 years after anterior transmuscular transposition, 75% of patients who underwent unilateral procedures reported improvement [23], and 68% of patients with bilateral surgery reported improvement [23]. Nonsmokers had significantly better outcomes than smokers in the follow-up study of 119 operated cases [23], while there were no significant differences in outcomes for patients with workers' compensation/litigation, obesity, concomitant carpal tunnel syndrome, or abnormal preoperative nerve conduction studies [23].

Patients with longer and more severe preoperative symptoms were more likely to report unsatisfactory outcomes after in situ ulnar nerve decompression [31], though patients may improve with ulnar nerve decompression even in the setting of muscular atrophy [31]. In a study of 42 consecutive cases of cubital tunnel syndrome with muscular atrophy, 45% of patients noted improvement in sensory deficits and 57% showed improvement in motor deficits at 6-month follow-up [31]. At mean final follow-up of 39.8 months, 76% of patients with muscular atrophy had improvement in their atrophy [31], and nearly 80% of patients with muscular atrophy were satisfied with the postoperative result [31]. Patients with a longer duration of atrophy and/or pseudoneuroma identified at the time of surgery were less likely to experience improvement in their atrophy [31].

Electrodiagnostic severity does not predict short- to midterm outcomes of cubital tunnel release surgery [12], but patient-reported preoperative disease severity may predict the expected postoperative change in ulnar nerve functional improvement [12]. Patients who underwent cubital tunnel release had a significant short-term improvement in their QuickDASH scores regardless of EDX diagnosis [35], and the patient-reported outcome of surgical treatment of cubital tunnel syndrome is good but is affected by preoperative symptom severity [25]. Improvement in pain and function after cubital tunnel release may be associated with an improvement in symptoms both within and outside the ulnar nerve distribution [1], and cubital tunnel release resulted in clinically relevant relief of hand symptoms [3]. The majority of patients undergoing revision cubital tunnel release and submuscular transposition have relief of symptoms [2], and patients with an anomalous muscle (AE) experience quicker symptom improvement after cubital tunnel release than those without the anomalous muscle [24]. Symptoms recurred at a rate of 3.6% after endoscopic cubital tunnel release [18]. In a review of 100 patients after repeat cubital tunnel surgery, a significant proportion (77%) can experience either motor and/or sensory improvement, with 23% achieving complete recovery from symptoms at final follow-up [10].

The classification of failed cubital tunnel syndrome includes persistence of the same preoperative symptoms with no change in clinical status [30], may present as relief of symptoms for several months to years followed by recurrent problems [30], or may present as new symptoms of neurologic loss or pain after the initial surgery [30]. If sensory loss far exceeds motor complaints, a sensory neuropathy should be considered [30]. If motor complaints exceed sensory complaints, compression in the Guyon canal should be considered, especially if proximal extrinsic hand muscles are normal and there is no thenar atrophy [30]. If there is additional thenar atrophy, radiculopathy or rarely compression in the thoracic outlet should be considered [30]. If extrinsic motors are equally involved, brachial plexus neuritis can be considered or upper motor neuron disease if deep tendon reflexes are increased [30]. Failure to relieve symptoms may imply an incomplete decompression of the primary surgical procedure or an incorrect diagnosis [30]. Recurrence of symptoms after a period of 6 months or more after initial relief usually implies a new site of ulnar nerve compression in the previous surgical field [30]. Severe causalgia-type pain at the elbow radiating into the medial aspect of the forearm suggests a neuroma of the medial antebrachial cutaneous nerve (MABC) [30], while severe causalgia-type pain in the ulnar nerve distribution suggests an injury to the ulnar nerve itself [30]. Percussion along the course of the ulnar nerve above the area of previous surgery will result in paresthesia and pain in the ulnar nerve distribution if there is a problem with the ulnar nerve itself [30]. Palpation along the course of the ulnar nerve in the distal forearm progressing to the region of the surgical site will result in deep pain distal to the previous surgical site if a new compression point has developed at the site of the distal surgical exposure [30].

Investigations

Epidemiology and Clinical Presentation: Cubital tunnel syndrome is the second most common entrapment neuropathy of the upper extremity, occurring behind carpal tunnel syndrome [10], with an incidence reported to be nearly 21 cases per 100,000 people per year [10]. Pain is not a common symptom, though an aching pain localized to the elbow or proximal forearm may be reported [10]. Typical presentation includes worsening sensory numbness of the hand and digits in an ulnar distribution [10], while progression may involve motor weakness of the hypothenar musculature and clawing of the hand due to loss of intrinsic musculature [10]. Diagnosis is made by clinical history and physical examination, with adjunct electrophysiology and imaging as needed [10].

Physical Examination: A detailed ulnar nerve examination should assess sensation in the distribution of the dorsal ulnar cutaneous nerve [10]. The dorsal ulnar cutaneous nerve innervates the ulnar aspect of the dorsum of the hand and arises from the ulnar nerve approximately 6 cm proximal to the wrist [10]. Diminished sensation in the dorsal ulnar cutaneous nerve territory indicates a lesion proximal to this branch, likely within the cubital tunnel [10], whereas preserved dorsal sensation suggests the lesion may be localized to Guyon canal in the wrist [10]. Subluxation or dislocation of the ulnar nerve during elbow flexion can be palpated and may be associated with increased symptoms [10]. Ulnar nerve mobility may be associated with dislocation of the medial head of the triceps [10], and identification of dislocating structures is important as it may affect surgical decision making [10].

Electrophysiology: Electrophysiology is helpful to ensure proper diagnosis and targeted treatment [10]. Electrodiagnostic severity (EDS) may not have prognostic value for patients undergoing cubital tunnel decompression [12].

Ultrasonography: Ultrasonography demonstrates hypoechoic, enlarged nerve fascicles with a sensitivity of 46% to 100% and specificity of 43% to 97% [10].

MRI: MRI demonstrates enlarged, T2-hyperintense nerve lesions proximal to a point of compression with distal muscle atrophy, with sensitivity as high as 95% and specificity of 80% [10]. MRI is an effective diagnostic modality for ulnar nerve palsy caused by synovial protrusion in synovial chondromatosis of the elbow [54]. Clinicians should be aware of primary synovial chondromatosis as a causative factor of cubital tunnel syndrome [54]. Only a small number of individuals with MRI evidence of an anconeus epitrochlearis muscle (AEM) had clinical evidence of ulnar neuropathy [69].

Other Considerations: Patients who undergo carpal tunnel release are 15 times more likely to undergo cubital tunnel release than the general population [6], and patients who undergo cubital tunnel release are 11.5 times more likely to undergo carpal tunnel release [6]. Cubital tunnel decompression is associated with prior trauma to the anatomic site [62]. Patient-reported preoperative disease severity may predict the expected postoperative change in ulnar nerve functional improvement [12]. Endoscopic cubital tunnel decompression facilitates inspection of the ulnar nerve so that selective release of compressive tissue can readily be performed [63]. Endoscopic cubital tunnel decompression has gained popularity with early short-term results showing satisfactory outcomes and minimal complications [13]. Endoscopic techniques have shown outcomes similar to in situ decompression for symptom relief and return to work [10]. Patients report higher scar satisfaction with endoscopic techniques compared to open techniques [10]. A nonrandomized level III study reported a 60% patient satisfaction rate with in situ decompression compared with a 79% rate in the endoscopic group [10]. Dützmann et al. found no significant differences in long-term outcomes after open and retractor-endoscopic in situ decompression of the ulnar nerve [10]. A double-blind, prospective randomized controlled study found equivalent outcomes at 2 years in endoscopic and open releases [10]. A meta-analysis by Buchanan et al. of 655 patients showed no significant differences in Bishop scores or visual analog scores between endoscopic and in situ decompression groups [10]. A meta-analysis by Aldekhayel et al. found no significant difference between endoscopic and open treatments in terms of complications, outcomes, and reoperation rates [10]. Symptoms recurred at a rate of 3.6% after Hoffmann and Siemionow's endoscopic cubital tunnel release [18], and the recurrence rate after endoscopic cubital tunnel release is comparable to other endoscopic or open techniques [18]. The risk of revision cubital tunnel release within 3 years is low [14]. For a reoperation to be successful, the ulnar nerve must be examined and all potential levels of compression must be released [15]. In patients with recurrent symptoms, a significant proportion (77%) can experience either motor and/or sensory improvement after revision cubital tunnel decompression [10]. In patients with recurrent symptoms, 23% achieve complete recovery from symptoms at final follow-up after revision cubital tunnel decompression [10]. Complete recovery in recurrent cases may be due to pain relief even when neurologic findings do not improve [10]. Improvement in pain and function after cubital tunnel release may be associated with improvement in symptoms both within and outside the ulnar nerve distribution [1]. The majority of patients undergoing revision cubital tunnel release and submuscular transposition have relief of symptoms [2]. Cubital tunnel release resulted in clinically relevant relief of hand symptoms [3]. Patients with an anomalous muscle (AE) experience quicker symptom improvement after cubital tunnel release than those without the anomalous muscle [24]. Postoperative results and complications for concomitant endoscopic carpal and cubital tunnel release are comparable to releases performed alone [11]. All ulnar nerves remained anteriorly transposed and improvement of symptoms occurred in all patients undergoing anterior transposition with endoscopic assistance [70].

Treatment

Non-Operative

The provided evidence base does not contain specific data regarding conservative management options such as physical therapy, NSAIDs, or weight loss; therefore, this section focuses exclusively on operative interventions supported by the available literature.

Operative

Indications: Patients presenting with ulnar nerve subluxation or dislocation that is apparent and reproducible during elbow flexion on physical examination should be considered for anterior transposition [10]. In contrast, in situ decompression is feasible and cost-effective for patients with ulnar neuropathy who show no evidence of active subluxation [10]. Most surgeons utilize more than one operative procedure in the treatment of cubital tunnel syndrome, with the selection of the specific technique influenced by patient factors and surgeon preference [38].

Surgical Approach / Technique: Open randomized controlled trials are currently underway to provide evidence-based recommendations regarding the efficacy, patient treatment experience, and safety profile of open versus endoscopic methods [5]. Endoscopic cubital tunnel release is characterized as a minimally invasive, simple, and fast procedure that facilitates smaller incisions, faster recovery, and minimal scarring [27]. Safety and efficacy data indicate that endoscopic techniques yield outcomes similar to in situ decompression regarding symptom relief and return to work [10]. Furthermore, endoscopic cubital tunnel release demonstrates safety and efficacy comparable to more invasive procedures [27]. Arthroscopic ulnar nerve decompression appears to be a useful procedure for the treatment of cubital tunnel syndrome when performed concurrently with elbow arthroscopic debridement arthroplasty [37]. A 2-stage local anesthetic injection method safely introduces local anesthetic within the cubital tunnel, achieving comfort, sufficient visualization, and the ability to decompress multiple compression sites through a minimal incision [42]. Decompression of the ulnar nerve under local anaesthetic is a reliable procedure that is well tolerated by the majority of patients [56]. Good pain control can be achieved during all steps of wide-awake surgery using local anaesthesia with adrenaline for ulnar nerve decompression and medial epicondylectomy [60].

Revision: The majority of patients undergoing revision cubital tunnel release and submuscular transposition experience relief of symptoms [2]. In patients with recurrent symptoms, a significant proportion (77%) can experience either motor and/or sensory improvement after revision cubital tunnel decompression [10]. Following revision cubital tunnel decompression, 23% of patients achieve complete recovery from symptoms at final follow-up [10]. The risk of revision cubital tunnel release was low [14], and the incidence of failure requiring ipsilateral revision surgery after cubital tunnel release remained steadily low (1.4%) during the study period [22].

Comparison of Techniques: A recent Cochrane review demonstrated no difference in symptom severity scores at follow-up (6 and 12 months) between in situ decompression and anterior transposition techniques [10]. In situ decompression has a reported success rate of 65.3% to 94.1% [10], while subcutaneous transposition has a reported success rate of 77.7% to 94% [10]. Complication rates for in situ decompression are reported to be 3% [10], whereas complication rates for transposition are reported to be higher, up to 14% [10]. Short-term complication rates for ulnar nerve transposition are higher (9.6%) than for in situ cubital tunnel release (3.6%) [21]. Rates of secondary surgery were higher in patients undergoing anterior transposition (in situ release 2.5% vs anterior transposition 11.1%) [10]. Postoperative results and complications for concomitant endoscopic carpal and cubital tunnel release are comparable to endoscopic carpal and cubital tunnel releases performed alone [11].

Outcomes: Improvement in pain and function after cubital tunnel release may be associated with an improvement in symptoms both within and outside the ulnar nerve distribution [1]. Cubital tunnel release resulted in clinically relevant relief of hand symptoms [3]. A meta-analysis represents the best cumulative evidence to date examining the surgical management of cubital tunnel syndrome [7]. Short-term complication rates of cubital tunnel surgery are low (5.6%) [21]. Lower reimbursement for endoscopic cubital tunnel release is likely related to lack of a dedicated current procedural terminology code [29].

Complications

Infection (PJI): Postoperative infections are uncommon, occurring in approximately 2.17% of Medicare cases following cubital tunnel release [72]. Preoperative antibiotics do not demonstrate benefit for patients undergoing uncomplicated ulnar nerve releases at the elbow [78] and do not significantly decrease the risk for postoperative infections in patients, regardless of patient comorbidities [78].

Nerve palsy: Complications from in situ decompression and anterior transposition include ulnar instability, infection, and medial antebrachial cutaneous nerve injury [10]. Short-term complication rates are higher for ulnar nerve transposition (9.6%) than for in situ cubital tunnel release (3.6%) [21]. Endoscopic cubital tunnel decompression shows satisfactory outcomes and minimal complications [13], with symptoms recurring at a rate of 3.6% after Hoffmann and Siemionow's endoscopic cubital tunnel release [18].

Wound complications: Complication rates are reported to be 3% for in situ decompression and higher (up to 14%) for transposition [10]. The short-term complication rates of cubital tunnel surgery are low (5.6%) [21].

Other Considerations: Improvement in pain and function after cubital tunnel release may be associated with an improvement in symptoms both within and outside the ulnar nerve distribution [1]. The majority of patients undergoing revision cubital tunnel release and submuscular transposition have relief of symptoms [2]. Rates of secondary surgery were higher in patients undergoing anterior transposition (in situ release 2.5% vs anterior transposition 11.1%) [10]. The secondary surgery rate after cubital tunnel surgery was 5.7% overall [73], with higher rates observed in patients with prior elbow trauma and those undergoing ulnar nerve transposition [73]. The rate of revision surgery following cubital tunnel release with transposition is quite low, with no major differences in revision rates among different types of surgical transposition [74]. The incidence of failure requiring ipsilateral revision surgery after cubital tunnel release remained steadily low (1.4%) [22]. Results of revision surgery for recurrent or persistent cubital tunnel syndrome are less predictable and satisfying than primary surgery [33]; however, in patients with recurrent symptoms, 77% can experience either motor and/or sensory improvement after revision cubital tunnel decompression, though only 23% achieve complete recovery from symptoms at final follow-up [10]. Complete recovery may be due to pain relief even when neurologic findings do not improve [10]. Patients with severe and chronic compression, atrophy, and dense sensory loss should be cautioned that surgery will arrest the progression and improve their symptoms but will not return normal strength or sensation [23]. In a follow-up study of 119 operated cases at least 2 years after anterior transmuscular transposition, 75% of patients who underwent unilateral procedures reported improvement, compared to 68% of patients with bilateral surgery [23]. Nonsmokers had significantly better outcomes than smokers following anterior transposition [23]. There were no significant differences in outcomes in patients with workers' compensation/litigation, obesity, concomitant carpal tunnel syndrome, or abnormal preoperative nerve conduction studies following anterior transposition [23].

Recovery

Light activity (weeks): Patients may resume desk work and light activities of daily living sooner when the elbow is mobilized immediately postoperatively [46]. Open in situ release is associated with an acceptable return-to-work time, comparable to other techniques [51].

Full activity (months): At short- to mid-term follow-up, 85% of overhead or throwing athletes return to sporting activity after ulnar nerve transposition, with 72% resuming their previous level of performance [68]. At mid-term follow-up, 92% of overhead athletes return to sport after ulnar nerve transposition, with 62% resuming their previous level of performance [66]. In the active duty population, there is no benefit for transposing the ulnar nerve for primary cubital tunnel syndrome regardless of preoperative nerve stability [48].

Complete recovery / outcome plateau (months): Differences in patient-rated function following in situ decompression and ulnar nerve transposition normalize by the third month after surgery [71]. Improvement in pain and function after cubital tunnel release may be associated with symptom relief both within and outside the ulnar nerve distribution [1]. The patient-reported outcome of surgical treatment is good but is affected by preoperative symptom severity [25]. Although outcomes of ulnar nerve transposition are not always satisfactory in severe ulnar neuropathy, useful relief of symptoms can be achieved [76].

Rehabilitation protocol: Immediate mobilization of the elbow is recommended to facilitate earlier return to occupation [46]. Open in situ release produces reliably good results with a similar sized incision and is safer compared to other approaches [51].

Functional milestones: Patient-reported preoperative disease severity may predict the expected postoperative change in ulnar nerve functional improvement [12]. Electrodiagnostic severity may not have prognostic value for patients undergoing cubital tunnel decompression [12]. Cubital tunnel release resulted in clinically relevant relief of hand symptoms [3]. Decompressing the deep motor branch of the ulnar nerve allowed for spontaneous nerve recovery and reinnervation of ulnar nerve-innervated intrinsic muscles [50].

Other Considerations: The majority of patients undergoing revision cubital tunnel release and submuscular transposition have relief of symptoms [2]. However, results of revision surgery for recurrent or persistent cubital tunnel syndrome are less predictable and satisfying than primary surgery [33].

Key Evidence

  • [L3] Improvement in pain and function after cubital tunnel release may be associated with an improvement in symptoms both within and outside the ulnar nerve distribution. (10.1007/s11552-014-9688-9)
  • [L3] The majority of patients undergoing revision cubital tunnel release and submuscular transposition have relief of symptoms. (10.1016/j.jhsg.2025.100810)
  • [L3] Cubital tunnel release resulted in clinically relevant relief of hand symptoms. (10.1177/17531934241275487)
  • [L5] This article reviews related anatomy, clinical presentation, and current management options for cubital tunnel syndrome with an emphasis on contemporary outcomes research. (10.1016/j.jhsa.2015.03.011)
  • [L2] This study aims to provide an evidence-based recommendation on which method has the best efficacy, patient treatment experience, and safety profile for cubital tunnel syndrome by comparing open and endoscopic release. (10.1186/s12891-023-06234-y)
  • [L4] Patients who undergo carpal tunnel release are 15 times more likely to undergo cubital tunnel release than the general population, and those who undergo cubital tunnel release are 11.5 times more likely to undergo carpal tunnel release. (10.1177/1753193420980983)
  • [L1] This report represents the best cumulative evidence to date examining the surgical management of cubital tunnel syndrome. (10.1016/j.jhsa.2008.03.006)
  • [L4] To our knowledge, this is the first study to classify ulnar nerve subluxation after endoscopic cubital tunnel release and describe a guideline for ensuing treatment. (10.1016/j.jhsg.2020.05.001)
  • [L4] This treatment approach leads to superior range of motion, improved or resolved ulnar neuropathy, and good to excellent long-term functional outcomes. (10.1016/j.jse.2023.12.003)
  • [L4] Postoperative results and complications are comparable to endoscopic carpal and cubital tunnel releases performed alone. (10.1007/s11552-013-9552-3)
  • [L3] Patient-reported preoperative disease severity may predict the expected postoperative change in ulnar nerve functional improvement, and EDS may not have prognostic value for patients undergoing cubital tunnel decompression. (10.1016/j.jse.2024.01.055)
  • [L5] Endoscopic cubital tunnel decompression has gained popularity with early short-term results being encouraging, showing satisfactory outcomes and minimal complications. (10.1136/jisakos-2020-000506)
  • [L3] The risk of revision cubital tunnel release was low. (10.1097/corr.0000000000002629)
  • [L4] For a reoperation to be successful, the ulnar nerve must be examined and all potential levels of compression must be released. (10.2106/jbjs.24.00493)
  • [L4] Symptoms recurred at a rate of 3.6% after Hoffmann and Siemionow's endoscopic cubital tunnel release, which is comparable to other endoscopic or open techniques. (10.1016/j.jhsg.2020.03.006)
  • [L4] The panel reached consensus on the designation of critical or noncritical for all steps of a carpal tunnel release, all but 1 step of an ulnar nerve transposition, and all but 1 step of open reduction and internal fixation of the distal part of the radius. (10.2106/jbjs.17.00654)
  • [L3] The short-term complication rates of cubital tunnel surgery are low (5.6%), but higher for ulnar nerve transposition (9.6%) than in situ cubital tunnel release (3.6%). (10.1016/j.jhsa.2016.07.033)
  • [L4] The incidence of failure requiring ipsilateral revision surgery after cubital tunnel release remained steadily low (1.4%) during the study period. (10.1016/j.jse.2016.10.028)
  • [L3] Patients with an AE experience quicker symptom improvement after cubital tunnel release than those without the anomalous muscle. (10.1016/j.jhsa.2017.06.033)
  • [L3] The patient-reported outcome of surgical treatment of cubital tunnel syndrome is good but is affected by preoperative symptom severity. (10.1016/j.jhsa.2009.05.014)
  • [L4] The purpose of this review is to summarize the most up-to-date literature regarding cubital tunnel syndrome and propose a treatment algorithm to provide clarity about the challenges of treating this complex patient population. (10.1016/j.jhsg.2022.07.008)
  • [L5] Endoscopic cubital tunnel release is a minimally invasive, simple, and fast procedure that allows for smaller incisions, faster recovery, and minimal scarring, with safety and efficacy shown to be comparable to more invasive procedures. (10.1016/j.jhsa.2010.07.030)
  • [L3] Lower reimbursement is likely related to lack of a dedicated current procedural terminology code for endoscopic cubital tunnel release. (10.1177/1558944716679610)
  • [L4] Results of revision surgery for recurrent or persistent cubital tunnel syndrome are less predictable and satisfying than primary surgery. (10.1016/j.jhsa.2011.11.024)
  • [L4] Men with cubital tunnel syndrome are more likely to present with muscle atrophy than women. (10.1177/1558944716643096)
  • [L4] Patients who underwent cubital tunnel release had a significant short-term improvement in their QuickDASH scores, regardless of EDX diagnosis. (10.1016/j.jhsg.2024.08.013)
  • [L4] This technique appears to be a useful procedure for treatment of cubital tunnel syndrome at the time of elbow arthroscopic debridement arthroplasty. (10.1016/j.jhsa.2012.01.003)
  • [L4] Most surgeons use more than one operative procedure in their treatment of patients with cubital tunnel syndrome and the selection of the operative procedure is influenced by patient factors and surgeon preference. (10.1007/s11552-008-9133-z)
  • [L3] However, no significant relationships between adaptations in shoulder strength or ROM were related to chronic structural adaptations of the elbow. (10.1177/03635465251317509)
  • [L5] The ulnar tunnel is a dynamic space with dimensions and relationships that are influenced by wrist motion. (10.1016/j.jhsa.2010.02.028)
  • [L5] The area within the cubital tunnel decreases beyond 90° of elbow flexion. (10.1016/j.jhsa.2011.09.014)
  • [L4] The authors describe a 2-stage local anesthetic injection method that safely introduces local anesthetic within the cubital tunnel, achieving comfort, sufficient visualization, and the ability to decompress multiple compression sites through a minimal incision. (10.1016/j.jhsa.2022.04.004)
  • [L5] With elbow flexion, the ulnar nerve did not move appreciably in the distal–proximal direction directly at the cubital tunnel, but maximal excursion was in the fatty region proximal to the elbow. (10.1016/j.jhsa.2012.03.016)
  • [L5] The humeral trochlea protrudes into the cubital tunnel during elbow flexion, causing dynamic morphologic changes in the ulnar nerve. (10.1016/j.jse.2022.05.026)
  • [L3] Patients returned to their occupation sooner when the elbow had been mobilized immediately. (10.2106/00004623-200011000-00005)
  • [L4] In the active duty population there is no benefit for transposing the ulnar nerve for the surgical treatment of primary cubital tunnel syndrome, regardless of preoperative nerve stability. (10.1016/j.jhsa.2018.06.106)
  • [L4] Decompressing the patient's deep motor branch of the ulnar nerve allowed for spontaneous nerve recovery and reinnervation of his ulnar nerve innervated intrinsic muscles. (10.1016/j.jhsg.2024.02.001)
  • [L4] Until more information regarding long-term results and the rate of nerve injury is available, open in situ release produces reliably good results with a similar sized incision and acceptable return to work time, and is safer. (10.1016/j.jhsa.2014.05.012)
  • [L4] To the best of our knowledge, this is the first study showing that shoulder position changes the ulnar nerve strain around the elbow in living patients with CubTS. (10.1016/j.jse.2015.01.014)
  • [L4] However, more than half of the athletes in our analysis sustained an ipsilateral shoulder or elbow injury. (10.1016/j.jseint.2020.10.026)
  • [Case_report] MRI is an effective diagnostic modality, and clinicians should be aware of primary synovial chondromatosis as a causative factor of cubital tunnel syndrome. (10.1177/1758573216683396)
  • [L3] Increased elbow flexion in patients with CuTS influences the intraneural blood flow of the ulnar nerve. (10.1016/j.jhsa.2021.06.024)
  • [L4] Decompression of the ulnar nerve under local anaesthetic is a reliable procedure, which is well tolerated by the majority of patients. (10.1054/jhsb.2000.0525)
  • [L3] The mechanism of provocation of symptoms of cubital tunnel syndrome by the elbow flexion test could not be explained simply by dynamic pressure in the cubital tunnel, and other pathophysiological factors could also be contributing. (10.1016/j.jhsa.2010.11.013)
  • [L4] Ulnar nerve gliding was most severe during passive wrist movement in elbow flexion and forearm supination. (10.5397/cise.2024.00934)
  • [L4] Good pain control can be achieved during all steps of the procedure. (10.1177/17531934241252518)
  • [L4] Cubital tunnel decompression is associated with prior trauma to the anatomic site. (10.1016/j.jhsa.2017.07.009)
  • [L4] The endoscopic approach facilitates inspection of the ulnar nerve so that selective release of the tissue that compresses the nerve can readily be performed. (10.1177/1753193408094443)
  • [L4] At mid-term follow-up, 92% of overhead athletes returned to sport after ulnar nerve transposition, with 62% resuming their previous level of performance. (10.1016/j.jse.2020.02.001)
  • [L4] At short- to mid-term follow up, 85% of overhead or throwing athletes were able to return to sporting activity after ulnar nerve transposition, with 72% resuming their previous level of performance. (10.1016/j.arthro.2018.10.073)
  • [L4] Only a small number of individuals with MRI evidence of an AEM had clinical evidence of ulnar neuropathy. (10.1016/j.jse.2018.03.021)
  • [L4] All ulnar nerves remained anteriorly transposed and improvement of symptoms occurred in all patients. (10.1177/1753193410381675)
  • [L2] In the 3rd month after surgery, differences in patient-rated function following in situ decompression and ulnar nerve transposition have normalized. (10.1016/j.jhsa.2015.06.066)
  • [L3] Postoperative infections are uncommon, occurring in approximately 2.17% of Medicare cases following cubital tunnel release. (10.1177/2325967118772799)
  • [L4] The secondary surgery rate after cubital tunnel surgery was 5.7% overall, but higher for patients with prior elbow trauma and for patients undergoing ulnar nerve transposition. (10.1016/j.jhsa.2017.01.020)
  • [L3] The rate of revision surgery following cubital tunnel release with transposition is quite low, and there do not appear to be major differences in the rate of revision among the different types of surgical transposition, indicating that a true subcutaneous transposition may be adequate. (10.1016/j.jhsg.2025.100815)
  • [L4] Although the outcome of ulnar nerve transposition is not always satisfactory in severe ulnar neuropathy, useful relief of symptoms can be achieved. (10.1177/1753193408092252)
  • [L4] Preoperative antibiotics do not demonstrate benefit for patients undergoing uncomplicated ulnar nerve releases at the elbow and do not significantly decrease the risk for postoperative infections in patients, regardless of patient comorbidities. (10.1177/15589447221107688)

See Also

  • Cubital Tunnel Syndrome

References

[1] Prospective Cohort Study of Symptom Resolution outside of the Ulnar Nerve Distribution following Cubital Tunnel Release. HAND. 2014. DOI: 10.1007/s11552-014-9688-9

[2] Efficacy of Submuscular Transposition for Revision Cubital Tunnel Release: Comparative Outcomes Analysis. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.100810

[3] Changes in hand function and health state utility after cubital tunnel release using the United Kingdom Hand Registry. Journal of Hand Surgery (European Volume). 2024. DOI: 10.1177/17531934241275487

[4] The Management of Cubital Tunnel Syndrome. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.03.011

[5] Protocol for Endoscopic Versus Open Cubital tunnel release (EVOCU): an open randomized controlled trial. BMC Musculoskeletal Disorders. 2023. DOI: 10.1186/s12891-023-06234-y

[6] The association between surgery for carpal and cubital tunnel syndrome: analysis of incidence and risk factors within a geographical area. Journal of Hand Surgery (European Volume). 2021. DOI: 10.1177/1753193420980983

[7] Simple Decompression Versus Anterior Subcutaneous and Submuscular Transposition of the Ulnar Nerve for Cubital Tunnel Syndrome: A Meta-Analysis. The Journal of Hand Surgery. 2008. DOI: 10.1016/j.jhsa.2008.03.006

[8] Classification and Treatment of Ulnar Nerve Subluxation Following Endoscopic Cubital Tunnel Release. Journal of Hand Surgery Global Online. 2020. DOI: 10.1016/j.jhsg.2020.05.001

[9] Bony encasement of the ulnar nerve secondary to heterotopic ossification of the elbow: an evaluation of long-term outcomes. Journal of Shoulder and Elbow Surgery. 2024. DOI: 10.1016/j.jse.2023.12.003

[10] Orthopaedic Knowledge Update 13 Ebook Without Multimedia. Neuropathies, Vascular Conditions: Buerger’s, Raynaud’s; Degenerative Conditions > Upper Extremity Neuropathies > Cubital Tunnel Syndrome.

[11] Concomitant Endoscopic Carpal and Cubital Tunnel Release: Safety and Efficacy. HAND. 2013. DOI: 10.1007/s11552-013-9552-3

[12] Electrodiagnostic severity does not predict short- to midterm outcomes of cubital tunnel release surgery. Journal of Shoulder and Elbow Surgery. 2024. DOI: 10.1016/j.jse.2024.01.055

[13] Endoscopic cubital tunnel decompression: state of the art. Journal of ISAKOS. 2021. DOI: 10.1136/jisakos-2020-000506

[14] What Factors Are Associated With Revision Cubital Tunnel Release Within 3 Years?. Clinical Orthopaedics & Related Research. 2023. DOI: 10.1097/corr.0000000000002629

[15] Risk Factors for Lumbar Spinal Fusion Reoperation: An Unusual Suspect. Journal of Bone and Joint Surgery. 2024. DOI: 10.2106/jbjs.24.00493

[18] Symptom Recurrence After Endoscopic Cubital Tunnel Release. Journal of Hand Surgery Global Online. 2020. DOI: 10.1016/j.jhsg.2020.03.006

[20] The Critical Portions of Carpal Tunnel Release, Ulnar Nerve Transposition, and Open Reduction and Internal Fixation of the Distal Part of the Radius. Journal of Bone and Joint Surgery. 2018. DOI: 10.2106/jbjs.17.00654

[21] Complication Rates of Cubital Tunnel Surgery: In situ Cubital Tunnel Release Compared with Ulnar Nerve Transposition. The Journal of Hand Surgery. 2016. DOI: 10.1016/j.jhsa.2016.07.033

[22] Risk factors for revision surgery following isolated ulnar nerve release at the cubital tunnel: a study of 25,977 cases. Journal of Shoulder and Elbow Surgery. 2017. DOI: 10.1016/j.jse.2016.10.028

[23] Green S Operative Hand Surgery. Median Nerve Compression at the Elbow and Forearm > Expected Outcome After Anterior Transposition of the Ulnar Nerve With Release of the Flexor-Pronator Muscle Origin for Cubital Tunnel Syndrome.

[24] Simultaneous Bilateral Carpal and Cubital Tunnel Releases. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.06.033

[25] Patient-Rated Outcome of Ulnar Nerve Decompression: A Comparison of Endoscopic and Open In Situ Decompression. The Journal of Hand Surgery. 2009. DOI: 10.1016/j.jhsa.2009.05.014

[26] Modern Treatment of Cubital Tunnel Syndrome: Evidence and Controversy. Journal of Hand Surgery Global Online. 2023. DOI: 10.1016/j.jhsg.2022.07.008

[27] Endoscopic Cubital Tunnel Release. The Journal of Hand Surgery. 2010. DOI: 10.1016/j.jhsa.2010.07.030

[29] Trends in Open and Endoscopic Cubital Tunnel Release in the Medicare Patient Population. HAND. 2016. DOI: 10.1177/1558944716679610

[30] Green S Operative Hand Surgery. Median Nerve Compression at the Elbow and Forearm > Recurrent Cubital Tunnel Syndrome.

[31] Orthopaedic Knowledge Update 13 Ebook Without Multimedia. Elbow Degenerative Conditions and Nerve Disorders > Nerve Disorders > Cubital Tunnel Syndrome.

[32] Campbell S Operative Orthopaedics 4 Volume Set. COMPRESSIVE NEUROPATHIES OF THE HAND, FOREARM, AND ELBOW > CUBITAL TUNNEL SYNDROME AND TARDY ULNAR NERVE PALSY.

[33] Recurrent or Persistent Cubital Tunnel Syndrome. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2011.11.024

[34] Muscle Atrophy at Presentation of Cubital Tunnel Syndrome. HAND. 2016. DOI: 10.1177/1558944716643096

[35] Electrodiagnostic Testing Predicts Postdecompression Outcomes in Patients With Cubital Tunnel Syndrome. Journal of Hand Surgery Global Online. 2024. DOI: 10.1016/j.jhsg.2024.08.013

[37] Arthroscopic Ulnar Nerve Decompression in the Setting of Elbow Osteoarthritis. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2012.01.003

[38] Selection of Operative Procedures for Cubital Tunnel Syndrome. HAND. 2008. DOI: 10.1007/s11552-008-9133-z

[39] Chronic Structural Adaptations of the Shoulder and Elbow Are Correlated in Professional Baseball Pitchers. The American Journal of Sports Medicine. 2025. DOI: 10.1177/03635465251317509

[40] Anatomy of the Ulnar Tunnel and the Influence of Wrist Motion on Its Morphology. The Journal of Hand Surgery. 2010. DOI: 10.1016/j.jhsa.2010.02.028

[41] Morphology of the Cubital Tunnel: An Anatomical and Biomechanical Study With Implications for Treatment of Ulnar Nerve Compression. The Journal of Hand Surgery. 2011. DOI: 10.1016/j.jhsa.2011.09.014

[42] Wide Awake Local Anesthesia No Tourniquet Endoscopic Cubital Tunnel Release. The Journal of Hand Surgery. 2022. DOI: 10.1016/j.jhsa.2022.04.004

[43] Laxity of the Ulnar Nerve During Elbow Flexion and Extension. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2012.03.016

[44] Dynamic analysis of the ulnar nerve and cubital tunnel morphology using ultrasonography: a cadaveric study. Journal of Shoulder and Elbow Surgery. 2022. DOI: 10.1016/j.jse.2022.05.026

[46] Stabilized Subcutaneous Ulnar Nerve Transposition with Immediate Range of Motion. The Journal of Bone and Joint Surgery-American Volume. 2000. DOI: 10.2106/00004623-200011000-00005

[48] Subcutaneous Anterior Transposition Versus In Situ Decompression of the Ulnar Nerve in an Active Duty Military Population. The Journal of Hand Surgery. 2018. DOI: 10.1016/j.jhsa.2018.06.106

[50] Posttraumatic Compressive Neuropathy of the Deep Motor Branch of the Ulnar Nerve Caused by Heterotopic Ossification. Journal of Hand Surgery Global Online. 2024. DOI: 10.1016/j.jhsg.2024.02.001

[51] Endoscopic Cubital Tunnel Release. The Journal of Hand Surgery. 2014. DOI: 10.1016/j.jhsa.2014.05.012

[52] Shoulder position increases ulnar nerve strain at the elbow of patients with cubital tunnel syndrome. Journal of Shoulder and Elbow Surgery. 2015. DOI: 10.1016/j.jse.2015.01.014

[53] Return to play rates after ulnar nerve transposition and decompression surgery: a retrospective analysis. JSES International. 2021. DOI: 10.1016/j.jseint.2020.10.026

[54] Ulnar nerve palsy caused by synovial protrusion in synovial chondromatosis of the elbow: a case report and literature review. Shoulder & Elbow. 2016. DOI: 10.1177/1758573216683396

[55] Dynamic Evaluation of Intraneural Microvascularity of the Ulnar Nerve Using Contrast-Enhanced Ultrasonography in Patients With Cubital Tunnel Syndrome. The Journal of Hand Surgery. 2022. DOI: 10.1016/j.jhsa.2021.06.024

[56] Ulnar Nerve Decompression in the Cubital Canal using Local Anaesthesia. Journal of Hand Surgery. 2001. DOI: 10.1054/jhsb.2000.0525

[57] Association Between the Elbow Flexion Test and Extraneural Pressure Inside the Cubital Tunnel. The Journal of Hand Surgery. 2011. DOI: 10.1016/j.jhsa.2010.11.013

[58] Biomechanical analysis of ulnar nerve gliding and elongation: implications for nonsurgical ulnar nerve release in cubital tunnel syndrome. Clinics in Shoulder and Elbow. 2025. DOI: 10.5397/cise.2024.00934

[60] Wide-awake surgery using local anaesthesia with adrenaline for ulnar nerve decompression and medial epicondylectomy. Journal of Hand Surgery (European Volume). 2024. DOI: 10.1177/17531934241252518

[62] Surgical Demographics of Carpal Tunnel Syndrome and Cubital Tunnel Syndrome Over 5 Years at a Single Institution. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.07.009

[63] Endoscopic Anatomical Nerve Observation and Minimally Invasive Management of Cubital Tunnel Syndrome. Journal of Hand Surgery (European Volume). 2008. DOI: 10.1177/1753193408094443

[66] Return to sporting activity after ulnar nerve transposition for isolated neuritis in competitive overhead athletes. Journal of Shoulder and Elbow Surgery. 2020. DOI: 10.1016/j.jse.2020.02.001

[68] Return to Sporting Activity After Ulnar Nerve Transposition for Isolated Neuritis in Competitive Overhead Athletes. Arthroscopy. 2018. DOI: 10.1016/j.arthro.2018.10.073

[69] Quantitative magnetic resonance imaging analysis of the cross-sectional areas of the anconeus epitrochlearis muscle, cubital tunnel, and ulnar nerve with the elbow in extension in patients with and without ulnar neuropathy. Journal of Shoulder and Elbow Surgery. 2018. DOI: 10.1016/j.jse.2018.03.021

[70] Anterior transposition of the ulnar nerve with endoscopic assistance. Journal of Hand Surgery (European Volume). 2010. DOI: 10.1177/1753193410381675

[71] Comparative Morbidity of Cubital Tunnel Surgeries: A Prospective Cohort Study. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2015.06.066

[72] Patient-Related Risk Factors for Infection Following Ulnar Nerve Release at the Cubital Tunnel: An Analysis of 15,188 Cases. Orthopaedic Journal of Sports Medicine. 2018. DOI: 10.1177/2325967118772799

[73] Rates of Complications and Secondary Surgeries After In Situ Cubital Tunnel Release Compared With Ulnar Nerve Transposition: A Retrospective Review. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.01.020

[74] Cubital Tunnel Revision After Transposition: A Single Center Experience. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.100815

[76] Severe Tardy Ulnar Nerve Palsy caused by Traumatic Cubitus Valgus Deformity: Functional Outcome of Subcutaneous Anterior Transposition. Journal of Hand Surgery (European Volume). 2008. DOI: 10.1177/1753193408092252

[78] The Effectiveness of Preoperative Antibiotic Prophylaxis in Ulnar Nerve Release at the Cubital Tunnel. HAND. 2022. DOI: 10.1177/15589447221107688

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International

Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees

Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.